血浆肾小管损伤与炎症生物标志物与儿童CKD进展相关
在CKiD前瞻性队列的651名儿童CKD患者中,中位随访5.7年,34%达到复合终点。多变量调整后,血浆KIM-1、TNFR-1或TNFR-2最高四分位者CKD进展风险显著高于最低四分位,而MCP-1、suPAR和YKL-40无独立关联。
要点
- 血浆KIM-1、TNFR-1、TNFR-2最高四分位者CKD进展风险显著增加。
- KIM-1和TNFR-1风险约4倍,TNFR-2约2倍。
- MCP-1、suPAR、YKL-40与CKD进展无独立关联。
核心结论
- 较高的血浆KIM-1、TNFR-1和TNFR-2与儿童CKD进展独立相关。
研究设计与样本
- 前瞻性CKiD队列研究纳入eGFR 30-90 ml/min per 1.73 m2的儿童,每年评估eGFR,入组后5个月采集血浆测生物标志物。
- 共评估651名儿童,中位年龄11岁,中位基线eGFR 53 ml/min per 1.73 m2,195名(30%)为肾小球病因。
主要发现
- 中位随访5.7年,223名儿童(34%)发生CKD进展(eGFR下降50%或 incident ESKD)。
- 多变量调整后,血浆KIM-1、TNFR-1或TNFR-2最高四分位者CKD进展风险显著高于最低四分位(KIM-1和TNFR-1风险约4倍,TNFR-2约2倍)。
- 血浆MCP-1、suPAR和YKL-40与CKD进展无独立关联。
- 按肾小球 vs 非肾小球病因分层,效应估计无显著差异。
临床怎么用
- 血浆KIM-1、TNFR-1、TNFR-2或可用于识别儿童CKD进展高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After accounting for known risk factors for CKD progression in children, clinical outcomes among children with CKD still vary substantially. Biomarkers of tubular injury (such as KIM-1), repair (such as YKL-40), or inflammation (such as MCP-1, suPAR, TNF receptor-1 [TNFR-1], and TNFR-2) may identify children with CKD at risk for GFR decline. METHODS: We investigated whether plasma KIM-1, YKL-40, MCP-1, suPAR, TNFR-1, and TNFR-2 are associated with GFR decline in children with CKD and in subgroups defined by glomerular versus nonglomerular cause of CKD. We studied participants of the prospective CKiD Cohort Study which enrolled children with an eGFR of 30-90 ml/min per 1.73 m2 and then assessed eGFR annually. Biomarkers were measured in plasma collected 5 months after study enrollment. The primary endpoint was CKD progression, defined as a composite of a 50% decline in eGFR or incident ESKD. RESULTS: Of the 651 children evaluated (median age 11 years; median baseline eGFR of 53 ml/min per 1.73 m2), 195 (30%) had a glomerular cause of CKD. Over a median follow-up of 5.7 years, 223 children (34%) experienced CKD progression to the composite endpoint. After multivariable adjustment, children with a plasma KIM-1, TNFR-1, or TNFR-2 concentration in the highest quartile were at significantly higher risk of CKD progression compared with children with a concentration for the respective biomarker in the lowest quartile (a 4-fold higher risk for KIM-1 and TNFR-1 and a 2-fold higher risk for TNFR-2). Plasma MCP-1, suPAR, and YKL-40 were not independently associated with progression. When stratified by glomerular versus nonglomerular etiology of CKD, effect estimates did not differ significantly. CONCLUSIONS: Higher plasma KIM-1, TNFR-1, and TNFR-2 are independently associated with CKD progression in children.
引用
- Greenberg JH, Abraham AG, Xu Y, et al. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children. J Am Soc Nephrol. 2020. PMID: 32234829. doi:10.1681/ASN.2019070723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。